PT - JOURNAL ARTICLE AU - Pehrson, Isabelle AU - Braian, Clara AU - Karlsson, Lovisa AU - Idh, Nina AU - Danielsson, Eva Kristin AU - Andersson, Blanka AU - Paues, Jakob AU - Das, Jyotirmoy AU - Lerm, Maria TI - DNA methylation profiling of immune cells from tuberculosis-exposed individuals overlaps with BCG-induced epigenetic changes and correlates with the emergence of anti-mycobacterial ‘corralling cells’ AID - 10.1101/2021.09.01.21262945 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.01.21262945 4099 - http://medrxiv.org/content/early/2021/09/03/2021.09.01.21262945.short 4100 - http://medrxiv.org/content/early/2021/09/03/2021.09.01.21262945.full AB - The mechanism of protection of the only approved tuberculosis (TB) vaccine, Bacillus Calmette Guérin (BCG) is poorly understood. In recent years, epigenetic modifications induced by BCG have been demonstrated to reflect a state of trained immunity. The concept of trained immunity is now explored as a potential prevention strategy for a variety of infections. Studies on human TB immunity are dominated by those using peripheral blood as surrogate markers for immunity. Here, we instead studied the lung compartment by obtaining induced sputum from subjects included in a TB contact tracing. CD3- and HLA-DR-positive cells were isolated from the collected sputum and DNA methylome analyses performed. Unsupervised cluster analysis revealed that DNA methylomes of cells from TB-exposed individuals and controls appeared as separate clusters, and the numerous genes that were differentially methylated were functionally connected. The enriched pathways were strongly correlated to previously reported epigenetic changes and trained immunity in immune cells exposed to the BCG vaccine in human and animal studies. We further demonstrated that similar pathways were epigenetically modified in human macrophages trained with BCG in vitro. Finally, we found evidence of an M. tuberculosis-triggered emergence of a non-macrophage cell population from BCG-trained macrophage cultures. These cells did not phagocytose M. tuberculosis, but ‘corralled’ the bacteria into focal points, resulting in limitation of bacterial growth. Altogether, our study demonstrates that similar epigenetic changes are induced by M. tuberculosis and BCG and suggests that the modifications promote transformation of macrophages (or an unknown progenitor) to establish a yet undescribed cellular defense mechanism which we term ‘corralling’, based on the metaphorical resemblance to sheepdog herding.Competing Interest StatementM.L. and J.D are authors of a patent application, Biomarker for detection of mycobacterial exposure and infection, submitted to the Swedish Intellectual Property Office on Feb 3rd 2021.Funding StatementThis study was funded through generous grants from Forskningsradet Sydostra Sverige (FORSS-932096), the Swedish Research Council (2015-02593 and 2018-02961) and the Swedish Heart Lung Foundation (20150709 and 20180613). J.D is a postdoctoral fellow supported through the Medical Infection and Inflammation Center (MIIC) at Linkoping University. The computations were enabled by resources provided by the Swedish National Infrastructure for Computing (SNIC) at Linkoping University campus partially funded by the Swedish Research Council through grant agreement no. 2018-05973. Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Etikprovningsnamnden i Linkoping (The regional ethical review board in Linkoping, Sweden) approval number #2016/237-31All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data will be available for research after final publication of the manuscript upon reasonable request.